CJC-1295 (no DAC) produces sustained, dose-dependent GH and IGF-1 increases [1] , while Ipamorelin selectively stimulates GH release without raising ACTH or cortisol [3]
HUBERMAN: You know, by my read, I can't see why anyone would use high doses of Hexarellin, maybe low doses of Hexarellin if your doctor thinks that's what's appropriate for you, but you'd really want to avoid that receptor desensitization because you could essentially turn off the system permanently
Our findings suggest that IF may offer a promising non-pharmacological intervention for managing RA in this population, potentially addressing both primary disease symptoms and associated metabolic complications 34
Meanwhile, individual users need practical guidance on starting doses, when to increase, how to manage breakthrough nausea, whether to reduce or push through side effects, and optimal maintenance dosing after achieving weight loss goals
The combination of unverified formulation, uncertain sterility, and unknown systemic effects creates a perioperative exposure that cannot be reliably risk-stratified
